[1]徐学静,曹小利,张之烽,等.血培养大肠埃希菌的药物敏感性分析及ESBLs编码基因的流行性分析[J].现代检验医学杂志,2016,31(01):55-57.[doi:10.3969/j.issn.1671-7414.2016.01.015]
 XU Xue-jing,CAO Xiao-li,ZHANG Zhi-feng,et al.Analysis on the Antimicrobial Susceptibilities and the Prevalenceof ESBLs Encoding Genes of Escherichia Coli Isolates Collected from Blood[J].Journal of Modern Laboratory Medicine,2016,31(01):55-57.[doi:10.3969/j.issn.1671-7414.2016.01.015]
点击复制

血培养大肠埃希菌的药物敏感性分析及ESBLs编码基因的流行性分析()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年01期
页码:
55-57
栏目:
论著
出版日期:
2016-01-25

文章信息/Info

Title:
Analysis on the Antimicrobial Susceptibilities and the Prevalenceof ESBLs Encoding Genes of Escherichia Coli Isolates Collected from Blood
作者:
徐学静曹小利张之烽宁明哲周万青张 葵沈 瀚
南京大学医学院附属鼓楼医院检验科,南京 210008
Author(s):
XU Xue-jingCAO Xiao-liZHANG Zhi-fengNING Ming-zheZHOU Wan-qing ZHANG KuiSHEN Han
Department of Medical Laboratory,the Affiliated Drum Tower Hospital of Medical School,Nanjing University,Nanjing 210008,China
关键词:
大肠埃希菌 超广谱β-内酰胺酶 血培养 耐药性 敏感性
分类号:
R378.21; Q503
DOI:
10.3969/j.issn.1671-7414.2016.01.015
文献标志码:
A
摘要:
目的 对2012年血培养分离121株大肠埃希菌的药物敏感性、产ESBLs情况及ESBLs编码基因blaCTX-M,blaTEM和blaSHV的分布进行分析。方法 收集2012年血培养非重复分离大肠埃希菌121株,使用WHONET 5.6分析耐药性; 采用双纸片协同法确认试验筛选产ESBLs菌; 聚合酶链反应(PCR)法和DNA测序法分析产ESBLs菌中blaCTX-M,blaTEMt blaSHV基因的流行性。结果 121株大肠埃希菌对广谱青霉素和二,三代头孢菌素、左旋氧氟沙星及复方新诺明都有较高的耐药性,耐药率大于40%; 对亚胺培南、哌拉西林/他唑巴坦、阿米卡星有较高的敏感性,耐药率小于12%; 121株大肠埃希菌中,86(88.7%)株产ESBLs,blaCTX-M,blaTEM和blaSHV基因的检出率分别为59.5%(72),38.8%(47)及4.1%(5)株; 其中,2(1.7%)株细菌同时携带blaCTX,blaTEM和blaSHV基因,30(24.8%)株细菌同时携带blaCTX和blaTEM基因,1(0.8%)株细菌同时携带blaSHV和blaTEM基因。结论 南京鼓楼医院血培养大肠埃希菌大多产ESBLs,以bla(CTX-M-14)的流行为主,对大多数的青霉素类、头孢菌素和单环类等常用抗菌药物耐药治疗时应根据药敏结果选择抗菌药物。
Abstract:
Objective To analyze the susceptibilities of Escherichia coli isolates collected from blood and the prevalence of ESBLs encoding genes.Methods A total of 121 Escherichia coliisolates collected from blood during 2012 were analyzed for antimicrobial susceptibilities by software of WHONET 5.6,the production of ESBLs was confirmed byconfirmatory phenotypic testing,PCR and DNA sequence were further implemented to analyze the ESBLs-encoding genes.Results 121 E.coli isolates displayed high resistance towards broad spectrum penicillin and 2ndor 3rd generation cephalosporins,levofloxacin and cotrimoxazole,with the resistance rates being more than 40%,susceptibilities to imipenem,piperacillin/tazobactam,amikacin were observed,with the resistance rates to be less than 12%,86(88.7%)out of 121 isolates were found to produce ESBLs.Among them,59.5%(72),38.8%(47)and 4.1%(5)were confirmed to carry blaCTX-M,blaTEM and blaSHV genes.Additionally,2(1.7%)isolates carried all the genes detected,30(24.8%)isolates carried both of blaCTX and blaTEM,1(0.8%)isolate carried bothof blaSHV andblaTEM.Conclusion Most of the E.coli isolates from the blood culture in Nanjing Gulou Hospital produce ESBLs,and displayed resistance towards most of the penicillins,cephalosporins and single amide antimicrobial agents should be chosen according to susceptibility results.

参考文献/References:

[1] Horner C,Fawley W,Morris K,et al.Escherichia coli bacteraemia:2 years of prospective regional surveillance(2010~2012)[J].J Antimicrob Chemother,2014,69(1):91-100.
[2] Clinical and Laboratory.Performance standards for a-ntimicrobial susceptibility testing; 22th informational supplement[S].Wayne:PA,CLSIM100-S22,2014.
[3] Dallenne C,Da Costa A,Decre D,et al.Development of a set of multiplexPCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae[J].J Antimicrob Chemother,2010,65(3):490-495.
[4] 孙国全,王 倩,褚云卓,等.28 179例血培养病原菌分布及耐药性分析[J].微生物学杂志,2013,33(5):102-105. Sun GQ,Wang Q,Chu YZ,et al.Pathogen distribution & drug resistance analysis from 28 179 blood cultures[J].Journal of Microbiology,2013,33(5):102-105.
[5] Ghafourian S,Sadeghifard N,Soheili S,et al.Extended spectrum beta-lactamases:definition,classification and epidemiology[J].Curr Issues Mol Biol,2015(17):11-22.
[6] Galán JC,González-Candelas F,Rolain JM,et al.Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance:from the resistome to genetic plasticity in the β-lactamases world[J].Front Microbiol,2013(4):9.
[7] Buynak JD.β-Lactamase inhibitors:a review of the pa-tent literature(2010-2013)[J].Expert Opin Ther Pat,2013,23(11):1469-1481.
[8] Oteo J,Pérez-Vázquez M,Campos J.Extended-spectrum[beta]-lactamase producing Escherichia coli:changing epidemiology and clinical impact[J].Curr Opin Infect Dis,2010,23(4):320-326.
[9] 杨小影,吴洪秋,李丽琴,等.珠海地区妇幼保健院大肠埃希菌产ESBLs的基因型研究[J].现代检验医学杂志,2014,29(4):40-42. Yang XY,Wu HQ,Li LQ,et al.Genotypes research for E.coli producing ESBLs in Zhuhai MCH[J].Journal of Modern Laboratory Medicine,2014,29(4):40-42.
[10] 张阮章,卢月梅,胡玉华,等.血流感染大肠埃希菌和肺炎克雷伯菌的ESBLs基因分型[J].中国微生态学杂志,2013,25(7):632-633,636. Zhang RZ,Lu YM,Hu YH,et al.Genotyping of ESBLs in Escherichia coliand Klebsiella pneumoniae isolates from blood culture specimens[J].Chinese Journal of Microecology,2013,25(7):632-633,636.

相似文献/References:

[1]谢娜,饶国洲,朱勇,等.单极射频低温等离子体杀菌的实验研究[J].现代检验医学杂志,2015,30(05):87.[doi:10.3969/j.issn.1671-7414.2015.05.026]
 XIE Na,RAO Guo-zhou,ZHU Yong,et al.Experimental Study on Monopole Radio Frequency Low Temperature Plasma Sterilization[J].Journal of Modern Laboratory Medicine,2015,30(01):87.[doi:10.3969/j.issn.1671-7414.2015.05.026]
[2]严海忠,王 娟,卢兰芬,等.糖尿病患者感染产ESBLs肠杆菌科细菌的耐药性及危险因素分析[J].现代检验医学杂志,2018,33(05):82.[doi:10.3969/j.issn.1671-7414.2018.05.022]
 YAN Hai-zhong,WANG Juan,LU Lan-fen,et al.Analysis of the Drug Resistance and Risk Factors of ESBLs-Producing Enterobacteriaceae Infection in Diabetics[J].Journal of Modern Laboratory Medicine,2018,33(01):82.[doi:10.3969/j.issn.1671-7414.2018.05.022]
[3]何家花,汪 阔,余成强.血流感染产超广谱 β-内酰胺酶大肠埃希菌的药敏结果及感染危险因素分析[J].现代检验医学杂志,2021,36(01):128.[doi:10.3969/j.issn.1671-7414.2021.01.032]
 HE Jia-hua,WANG Kuo,YU Cheng-qiang.Drug Sensitivity and Risk Factors Analysis of Escherichia Coli Producing Extended-spectrum β-lactamases by Bloodstream Infection[J].Journal of Modern Laboratory Medicine,2021,36(01):128.[doi:10.3969/j.issn.1671-7414.2021.01.032]
[4]谈 昀,丁晓勇,白 晓.产β-内酰胺酶大肠埃希菌的临床分布及耐药性分析[J].现代检验医学杂志,2015,30(02):74.[doi:10.3969/j.issn.1671-7414.2015.02.023]
 TAN Yun,DING Xiao-yong,BAI Xiao.Clinical Distribution and Drug-resistance Analysis of 1 587 Escherichia coli[J].Journal of Modern Laboratory Medicine,2015,30(01):74.[doi:10.3969/j.issn.1671-7414.2015.02.023]

备注/Memo

备注/Memo:
基金项目:南京市卫生局医学科技发展资金资助(QRX11191)。 作者简介:徐学静(1983-),女,主管技师,主要从事临床检验工作,Tel:13951829953,E-mail:xxuejing@hotmail.com。 通讯作者:沈 瀚,男,主任技师,E-mail:shenhan10366@sina.com。
更新日期/Last Update: 2016-01-20